People fleeing violence in Sudan find little aid at Chad border
At a transit camp here on the Chad-Sudan border, Najwa Isa Adam, 32, hands out bowls of pasta and meat to orphaned Sudanese children from al-Fashir, t...
Uganda has launched a trial vaccination program for the Sudan strain of Ebola as confirmed cases rise to three. With no approved vaccine for this strain, the trial aims to protect communities and strengthen outbreak response, according to the WHO.
Uganda has launched a trial vaccination program for the strain of Ebola responsible for the country’s latest outbreak, according to the World Health Organization (WHO), as the number of confirmed cases has increased to three.
The East African nation reported an Ebola outbreak in its capital, Kampala, last week, initially identifying a single case—a nurse who passed away on January 29.
Ministry of Health spokesperson Emmanuel Ainebyoona informed Reuters on Monday that the total number of cases has now risen to three, with two additional infections found among the deceased nurse’s family members.
In a post on X later that day, WHO’s Africa director, Matshidiso Moeti, confirmed that Uganda had also initiated a clinical trial for a vaccine targeting the Sudan strain of Ebola.
At present, there is no approved vaccine for this particular strain. The available vaccine is designed to combat the Zaire strain, which has caused a recent outbreak in the neighboring Democratic Republic of Congo.
Bruce Kirenga, head of the Makerere Lung Institute—the research organization conducting the trial—told local media that the vaccine was developed by the International Aids Vaccine Initiative (IAVI), and approximately 2,460 doses had been received for the program.
According to Uganda’s health ministry, the trial is focused on vaccinating individuals who have been in contact with confirmed cases.
Security concerns across Central Asia have intensified rapidly after officials in Dushanbe reported a series of lethal incursions originating from Afghan soil, marking a significant escalation in border violence.
Moscow and Kyiv painted very different pictures of the battlefield on Sunday, each insisting momentum was on their side as the fighting around Pokrovsk intensified.
U.S. President Donald Trump confirmed on Sunday that he had spoken with Venezuelan President Nicolas Maduro, but did not provide details on what the two leaders discussed.
Russia asserted on Monday (1 December) that its troops had seized the frontline Ukrainian towns of Pokrovsk and Vovchansk and were pushing ahead across multiple directions, a set of claims that Ukrainian officials have not confirmed.
French President Emmanuel Macron addressed critical issues surrounding Ukraine’s ongoing conflict, the role of American mediation, and European involvement during a press conference on Monday, reaffirming France’s commitment to supporting Ukraine's sovereignty and ensuring peace in the region.
The Democratic Republic of the Congo has declared the end of its 16th Ebola outbreak, closing a two month emergency in Kasai Province that pushed national and international teams into an intensive response.
The U.S. Food and Drug Administration Commissioner Marty Makary said on Saturday that data showed 10 children had died because of COVID-19 vaccination shots.
The Spanish agricultural sector has been placed on high alert following the confirmation that African Swine Fever (ASF) has resurfaced in the country for the first time in over thirty years.
French health experts are warning that the highly pathogenic H5 strain of bird flu, already devastating wild and farm animals, could evolve into a virus capable of human-to-human transmission — potentially sparking a pandemic worse than COVID-19.
China has overtaken the United States in the volume of medical research it publishes, showing a major shift in global scientific influence, according to the chief editorial leadership of Swiss-based scientific publisher Frontiers.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment